Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Other ORP type
Data sources: ZENODO
Zenodo
Claim

What are the potential risks of administering chemotherapy for head and neck cancer to patients with pre-existing neurological diseases?

descriptionPublicationkeyboard_double_arrow_right Other ORP type Under curationPublisher:Zenodo
Authors: Tripdatabase;

doi: 10.5281/zenodo.20518475

What are the potential risks of administering chemotherapy for head and neck cancer to patients with pre-existing neurological diseases?

Abstract

Chemotherapy for head and neck cancer patients with pre-existing neurological diseases may exacerbate neurological symptoms and increase the risk of vascular complications, including stroke.

Powered by OpenAIRE graph
Found an issue? Give us feedback